Mizuho Securities has upgraded its rating for Sarepta Therapeutics (NASDAQ: SRPT) from neutral to...
SRPT
HOUSTON – A groundbreaking discovery at Rice University has resolved a quantum conundrum that...
Breaking News & Top Stories